Protein Engineering - Industrializing design, development, and manufacturing of therapeutic proteins. - BioPharm International

ADVERTISEMENT

Protein Engineering
Industrializing design, development, and manufacturing of therapeutic proteins.


BioPharm International
Volume 24, Issue 11, pp. 50-54

REFERENCES

1. K.J. Hamblett et al., Clin. Cancer Res. 10 (20), 7063–7070 (2004).

2. J.R. Junutula et al., Clin. Cancer Res. 16 (19), 4769–4778 (2010).

3. J.S. Ma, Chim. Oggi 21 (6), 65–68 (2003).

4. A.R. Goerke and J.R. Swartz, Biotechnol. Bioeng. 102 (2), 400–416 (2009).

5. I.S. Carrico, B.L. Carlson, and C.R. Bertozzi, Nat. Chem. Biol. 3 (6), 321–322 (2007).

6. A.J. de Graaf et al., Bioconjugate Chem. 20 (7), 1281–1295 (2009).

7. R. Mamluk et al., MAbs 2 (2), 199–208 (2010).

8. H. Mao et al., Nat. Biotechnol. 28 (11), 1195–2002 (2010).

9. J. Swartz, J. Ind. Microbiol.and Biotechnol. 33 (7), 476–485 (2006).

10. E.A Burks et al., Proc. Natl. Acad. Sci. 94 (2), 412–417 (1997).

11. L. Jermutus, L.A. Ryabova, and A. Pluckthun, Curr. Opin. Biotechnol. 9 (5), 534–548 (1998).

12. M.C. Jewett et al., Mol. Syst. Biol. 4, 220–end page (2008).

13. A.R. Goerke and J.R. Swartz, Biotechnol. Bioeng. 99 (2), 351–367 (2008).

14. J.F. Zawada et al., Biotechnol. Bioeng. in press (2011).

15. M. He, New Biotechnol. 25 (2–3), 126–132 (2008).

16. T. Tsuboi et al., Infect. Immun. 76 (4), 1702–1708 (2008).

17. J. Swartz Nat. Biotechnol. 27, 731–732 (2009).


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

J&J Speeds Ebola Vaccine Development and Expands Production
October 24, 2014
Despite AbbVie Snub, Shire Says it Will Double Sales by 2020
October 24, 2014
Manufacturing Challenges of mAb Production: CHO or Plant Cells?
October 24, 2014
Celgene and Sutro Partner on ADC Development
October 24, 2014
GSK Accelerates Ebola Vaccine Development
October 24, 2014
Author Guidelines
Source: BioPharm International,
Click here